WallStreetZenWallStreetZen

NASDAQ: PRCT
Procept Biorobotics Corp Stock

$68.10-0.04 (-0.06%)
Updated May 17, 2024
PRCT Price
$68.10
Fair Value Price
N/A
Market Cap
$3.50B
52 Week Low
$24.83
52 Week High
$77.00
P/E
-32.12x
P/B
13.26x
P/S
16.13x
PEG
N/A
Dividend Yield
N/A
Revenue
$156.33M
Earnings
-$103.37M
Gross Margin
53.5%
Operating Margin
-63.47%
Profit Margin
-66.1%
Debt to Equity
0.45
Operating Cash Flow
-$104M
Beta
1.38
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PRCT Overview

PROCEPT BioRobotics Corporations is a surgical robotics company advancing solutions in urology. The company offers the AquaBeam Robotic System, an image-guided, surgical robotic system used in minimally invasive urologic surgery, with an initial focus on benign prostatic hyperplasia. It has an install base of 130 AquaBeam Robotic Systems worldwide, 78 of which are in the U.S. PROCEPT BioRobotics was incorporated in 2007 and is headquartered in Redwood City, CA.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PRCT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PRCT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PRCT is poor value based on its book value relative to its share price (13.26x), compared to the US Medical Devices industry average (4x)
P/B vs Industry Valuation
PRCT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more PRCT due diligence checks available for Premium users.

Be the first to know about important PRCT news, forecast changes, insider trades & much more!

PRCT News

Valuation

PRCT fair value

Fair Value of PRCT stock based on Discounted Cash Flow (DCF)
Price
$68.10
Fair Value
$55.82
Overvalued by
21.99%
PRCT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PRCT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-32.12x
Industry
30.6x
Market
30.97x

PRCT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
13.26x
Industry
4x
PRCT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PRCT's financial health

Profit margin

Revenue
$44.5M
Net Income
-$26.0M
Profit Margin
-58.3%
PRCT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PRCT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$382.9M
Liabilities
$118.9M
Debt to equity
0.45
PRCT's short-term assets ($329.19M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRCT's short-term assets ($329.19M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRCT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$32.3M
Investing
-$1.9M
Financing
$2.6M
PRCT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PRCT vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
PRCT$3.50B-0.06%-32.12x13.26x
AXNX$3.45B-0.18%-217.90x5.50x
LIVN$3.36B-1.46%-105.02x2.75x
TNDM$3.06B+0.79%-21.80x12.57x
ITGR$4.05B+1.61%41.13x2.66x

Procept Biorobotics Stock FAQ

What is Procept Biorobotics's quote symbol?

(NASDAQ: PRCT) Procept Biorobotics trades on the NASDAQ under the ticker symbol PRCT. Procept Biorobotics stock quotes can also be displayed as NASDAQ: PRCT.

If you're new to stock investing, here's how to buy Procept Biorobotics stock.

What is the 52 week high and low for Procept Biorobotics (NASDAQ: PRCT)?

(NASDAQ: PRCT) Procept Biorobotics's 52-week high was $77.00, and its 52-week low was $24.83. It is currently -11.56% from its 52-week high and 174.27% from its 52-week low.

How much is Procept Biorobotics stock worth today?

(NASDAQ: PRCT) Procept Biorobotics currently has 51,424,151 outstanding shares. With Procept Biorobotics stock trading at $68.10 per share, the total value of Procept Biorobotics stock (market capitalization) is $3.50B.

Procept Biorobotics stock was originally listed at a price of $41.94 in Sep 15, 2021. If you had invested in Procept Biorobotics stock at $41.94, your return over the last 2 years would have been 62.37%, for an annualized return of 27.43% (not including any dividends or dividend reinvestments).

How much is Procept Biorobotics's stock price per share?

(NASDAQ: PRCT) Procept Biorobotics stock price per share is $68.10 today (as of May 17, 2024).

What is Procept Biorobotics's Market Cap?

(NASDAQ: PRCT) Procept Biorobotics's market cap is $3.50B, as of May 20, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Procept Biorobotics's market cap is calculated by multiplying PRCT's current stock price of $68.10 by PRCT's total outstanding shares of 51,424,151.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.